Aligos Therapeutics (ALGS) Shares Outstanding (Diluted) (2021 - 2026)
Aligos Therapeutics (ALGS) recorded Shares Outstanding (Diluted) of 10.43 million in Q2 2026, up 0.8% from 10.35 million a year earlier and up 0.3% from the prior quarter.
Aligos Therapeutics (ALGS) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, Aligos Therapeutics reported Shares Outstanding (Diluted) of 9.88 million, up 57.8% from FY2024.
- Annual Shares Outstanding (Diluted) has a four-year compound annual growth rate of -30.5% (FY2021 to FY2025).
- Across earlier years, Shares Outstanding (Diluted) came in at 6.26 million in FY2024 (-90.3%), 64.26 million in FY2023 (+50.5%), 42.7 million in FY2022 (+0.7%) and 42.4 million in FY2021.
- The Q2 2026 figure is the highest quarterly Shares Outstanding (Diluted) since Q2 2024.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased for four consecutive quarters, with an average decline of 27.5% over the last eight quarters.
- Peak year-over-year performance for Shares Outstanding (Diluted) in the last five years was growth of 263.9% in Q1 2024, against a decline of 94.4% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 10.4 million (Q1 2026), 9.88 million (Q4 2025) and 10.37 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,164.36 Bn | 1,132.95 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 634.54 Bn | 553.07 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 502.85 Bn | 475.96 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 376.50 Bn | 330.88 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 303.65 Bn | 267.64 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 266.62 Bn | 240.30 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 241.17 Bn | 196.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 193.39 Bn | 167.59 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.45 Bn | 119.10 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Aligos Therapeutics | 52.21 Mn | -276.20 Mn | - | 10.43 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.43 Mn |
| Mar 31, 2026 | 10.40 Mn |
| Dec 31, 2025 | 9.88 Mn |
| Sep 30, 2025 | 10.37 Mn |
| Jun 30, 2025 | 10.35 Mn |
| Mar 31, 2025 | 8.71 Mn |
| Dec 31, 2024 | 6.26 Mn |
| Sep 30, 2024 | 6.27 Mn |
| Jun 30, 2024 | 156.65 Mn |
| Mar 31, 2024 | 156.15 Mn |
| Dec 31, 2023 | 64.26 Mn |
| Sep 30, 2023 | 43.50 Mn |
| Jun 30, 2023 | 43.22 Mn |
| Mar 31, 2023 | 42.91 Mn |
| Dec 31, 2022 | 42.70 Mn |
| Sep 30, 2022 | 42.76 Mn |
| Jun 30, 2022 | 42.67 Mn |
| Mar 31, 2022 | 42.51 Mn |
| Dec 31, 2021 | 42.40 Mn |
| Sep 30, 2021 | 42.40 Mn |
Aligos Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();